An overview of renal replacement therapy and health care personnel deficiencies in sub-Saharan Africa

Transplant International

Volumn 25, Issue 6, 2012, Pages 652-657

  Pozo, Marcos E ^a,b   Leow, Jeffrey J ^a   Groen, Reinou S ^a,c   Kamara, Thaim B ^a,d   Hardy, Mark A ^a,e   Kushner, Adam L ^a,e  

^a Surgeons OverSeas SOS   (United States)

^b UNIVERSIDAD DE LOS ANDES   (Colombia)

^c ROYAL TROPICAL INSTITUTE   (Netherlands)

^d Ministry of Health and Sanitation   (Sierra Leone)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

end stage renal disease; renal replacement therapies; renal transplantation; sub Saharan Africa

Indexed keywords

AFRICA SOUTH OF THE SAHARA; BENIN; BURKINA FASO; CAMEROON; CONFERENCE PAPER; COTE D'IVOIRE; DEMOCRATIC REPUBLIC CONGO; DIALYSIS; ETHIOPIA; GHANA; HEALTH CARE PERSONNEL; HEALTH CENTER; HUMAN; KENYA; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALI; MAURITIUS; NEPHROLOGIST; NIGERIA; PHYSICIAN; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RWANDA; SENEGAL; SOUTH AFRICA; TOGO;

AFRICA SOUTH OF THE SAHARA; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HUMANS; KIDNEY TRANSPLANTATION; MEDICALLY UNDERSERVED AREA; NEEDS ASSESSMENT; NEPHROLOGY; PHYSICIANS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84861203175     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01468.x     Document Type: Conference Paper

References (39)

1. Katz IJ, Gerntholtz T, Naicker S,. Africa and nephrology: the forgotten continent. Nephron Clin Pract 2011; 117: c320.
2. Moosa MR, Kidd M,. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int 2006; 70: 1107.
3. Grassmann A, Gioberge S, Moeller S, Brown G,. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005; 20: 2587.
4. Naicker S,. End-stage renal disease in sub-Saharan Africa. Ethn Dis 2009; 19: S1-13.
5. Bamgboye EL,. End-stage renal disease in sub-Saharan Africa. Ethn Dis 2006; 16: S2-5.
6. WHO. WHO global observatory on donation & transplantation 2011 [cited 2012 Jan 8]; Available from:.
7. U.S. Department of Health and Human Services-Organ Procurement and Transplantation Network 2012 [cited 2012 Jan 8]; Available from: http://optn.transplant.hrsa.gov/latestData/rptData.asp.
8. Bamgboye EL,. Hemodialysis: management problems in developing countries, with Nigeria as a surrogate. Kidney Int Suppl 2003; 63: s93.
9. Barsoum RS,. Chronic kidney disease in the developing world. N Engl J Med 2006; 354: 997.
10. Twagirumukiza M, De Bacquer D, Kips JG, de Backer G, Stichele RV, Van Bortel LM,. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. J Hypertens 2011; 29: 1243.
11. Cappuccio FP, Kerry SM, Adeyemo A, et al. Body size and blood pressure: an analysis of Africans and the African diaspora. Epidemiology 2008; 19: 38.
12. Addo J, Smeeth L, Leon DA,. Hypertension in sub-saharan Africa: a systematic review. Hypertension 2007; 50: 1012.
13. Dalal S, Beunza JJ, Volmink J, et al. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol 2011; 40: 885.
14. WHO. Global Status Report on Non-communicable diseases 2010 [cited 2012 Jan 8]; Available from: http://www.who.int/nmh/publications/ncd-report2010/en/.
15. Horton R,. Chronic diseases: the case for urgent global action. Lancet 2007; 370: 1881.
16. WHO. Global health risks: mortality and burden of disease attributable to selected major risks 2009 [cited 2012 Jan 8]; Available from: http://www.who.int/healthinfo/global-burden-disease/GlobalHealthRisks-report- full.pdf.
17. WHO. World Health Organization Global Statistics 2008 [cited 2012 Jan 8]; Available from: http://www.who.int/gho/publications/world-health-statistics/ 2011/en/index.html.
18. Alebiosu CO, Ayodele OO, Abbas A, Olutoyin AI,. Chronic renal failure at the Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria. Afr Health Sci 2006; 6: 132.
19. Barsoum RS,. Trends in unrelated-donor kidney transplantation in the developing world. Pediatr Nephrol 2008; 23: 1925.
20. Arogundade FA, Barsoum RS,. CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis 2008; 51: 515.
21. Ulasi II, Ijoma CK,. The enormity of chronic kidney disease in Nigeria: the situation in a teaching hospital in South-East Nigeria. J Trop Med 2010; 2010: 501957.
22. Mathers CD, Loncar D,. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
23. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S,. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333.
24. Humar A, Durand B, Gillingham K, Payne WD, Sutherland DE, Matas AJ,. Living unrelated donors in kidney transplants: better long-term results than with non-HLA-identical living related donors? Transplantation 2000; 69: 1942.
25. Ahmad N, Ahmed K, Khan MS, et al. Living-unrelated donor renal transplantation: an alternative to living-related donor transplantation? Ann R Coll Surg Engl 2008; 90: 247.
26. Gheith O, Sabry A, El-Baset SA, et al. Study of the effect of donor source on graft and patient survival in pediatric renal transplant recipients. Pediatr Nephrol 2008; 23: 2075.
27. Hamidi V, Andersen MH, Oyen O, Mathisen L, Fosse E, Kristiansen IS,. Cost effectiveness of open versus laparoscopic living-donor nephrectomy. Transplantation 2009; 87: 831.
28. Kumar A, Chaudhary H, Srivastava A, Raghavendran M,. Laparoscopic live-donor nephrectomy: modifications for developing nations. BJU Int 2004; 93: 1291.
29. Simforoosh N, Basiri A, Tabibi A, Shakhssalim N,. Laparoscopic donor nephrectomy - an Iranian model for developing countries: a cost-effective no-rush approach. Exp Clin Transplant 2004; 2: 249.
30. Davis CL,. How to increase living donation. Transpl Int 2011; 24: 344.
31. Lim W, Chadban S, Campbell S, Dent H, Russ G, McDonald S,. Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients. Transpl Int 2010; 23: 1207.
32. World Bank. World Bank Data Statistics 2011 [cited 2011 Jan 8 ]; Available from: http://siteresources.worldbank.org/DATASTATISTICS/Resources/POP. pdf.
33. WHO. WHO Global Health Observatory 2011 [cited 2012 Jan 8]; Available from: http://apps.who.int/ghodata/.
34. Kasier Family Foundation KF. Total Professional Active Physicians Nov 2011 2011 [cited 2012 Jan 8]; Available from: http://www.statehealthfacts.org/ comparemaptable.jsp?ind=934&cat=8.
35. WHO. World Health Statistics 2011 [cited 2012 Jan 8]; Avaiable from: http://www.who.int/gho/publications/world-health-statistics/2011/en/index.html.
36. Tuso PJ,. SERVE Ethiopia. Perm J 2009; 13: 51.
37. Matri AE, Elhassa EA, Abu-Aish H,. Renal replacement therapy resources in Africa. Arab J Nephrol Transplant 2008; 1: Available at: http://www.ajol.info/ index.php/ajnt/article/view/58814.
38. Fogazzi GB, Attolou V, Kadiri S, Fenili D, Priuli F,. A nephrological program in Benin and Togo (West Africa). Kidney Int Suppl 2003; 83: S56.
39. Medicare.gov. Dialysis Facility Compare 2012 [cited 2012 Jan 8]; Available from: http://www.medicare.gov/Dialysis.